This deep dive provides a comprehensive, clinical overview of Fibromyalgia (FMS), detailing its nature as a chronic pain disorder, its underlying pathophysiology, diagnostic criteria, and evidence-based management strategies.
Our sources:
https://www.ncbi.nlm.nih.gov/books/NBK540974/
https://www.nhs.uk/conditions/fibromyalgia/
https://www.mayoclinic.org/diseases-conditions/fibromyalgia/symptoms-causes/syc-20354780
https://my.clevelandclinic.org/health/diseases/4832-fibromyalgia
Core Definition and Symptoms
Fibromyalgia is defined as a long-term (chronic) condition characterized primarily by widespread musculoskeletal pain and tenderness throughout the body, lasting at least 3 months. Patients frequently describe the pain as a constant dull ache, although it can also be sharp, shooting, burning, or aching.
Key associated clinical features explored in the deep dive include:
• Fatigue and Sleep Disturbances: Debilitating fatigue is a core feature. Patients often experience poor sleep quality, such as light sleep, frequent awakenings, and non-restorative sleep. Nonrestorative sleep is considered the strongest predictor of widespread pain and increases the risk of developing the condition.
• Cognitive Dysfunction (\"Fibro Fog\"): Most patients report cognitive problems, referred to as \"fibro fog\". These issues include difficulty concentrating, memory problems, slowed processing speed, and confused speech.
• Central Sensitization: FMS is considered a disorder of pain regulation and is classified as a condition of central sensitization. This involves altered pain processing in the central nervous system (CNS), causing amplified neural signaling and hypersensitivity to pain. Patients may perceive pain from non-painful stimuli (allodynia) or feel extreme pain sensitivity (hyperalgesia).
• Co-occurring Conditions: The condition is frequently accompanied by psychiatric symptoms (30% to 50% experience depression or anxiety), and various somatic concerns, including irritable bowel syndrome (IBS), headaches (migraine, tension, cluster), and autonomic dysfunction (e.g., reduced heart rate variability, orthostatic hypotension).
Pathophysiological and Genetic Insights
The deep dive into pathophysiology reveals that the subjective experience of pain is influenced by alterations in functional brain connectivity and neurochemical balances.
• CNS Changes: Brain imaging studies show strong evidence of CNS alterations, including amplified pain response to stimuli and modifications in resting-state functional connectivity. Specific findings include premature brain aging, reduced total gray matter (especially in the anterior cingulate cortex and prefrontal cortex), and altered brain hub topology.
• Neurotransmitter Alterations: There are suggested deficits in GABAergic and glutamatergic modulation. Specifically, elevated glutamate levels in the right posterior insular region are associated with a decreased pain threshold.
• Etiology: While a single cause has not been identified, experts believe physical or emotional stressors (such as trauma or infection) can trigger symptoms in individuals who may have a genetic predisposition. First-degree relatives of patients have a 13.6 times higher incidence of developing fibromyalgia.
#medicine #medicalstudent #medicalpodcast #fibromyalgia #fibromyalgiatreatment #fibromyalgiasymptoms
","author_name":"Josh and Anna"}